ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,957Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 1006

$934K Total Retail Price of All Prescriptions

Rank: 47 out of 1006

490 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 490 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 12,992 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 510 477 1 3
SIMVASTATIN 504 471 2 1
WARFARIN SODIUM 452 422 3 8
FUROSEMIDE 451 424 4 6
LEVOTHYROXINE SODIUM 443 435 5 2
AMLODIPINE BESYLATE 369 366 6 4
ATORVASTATIN CALCIUM 279 261 7 5
METOPROLOL TARTRATE 267 220 8 7
METFORMIN HCL 244 207 9 10
OMEPRAZOLE 243 233 10 9
POTASSIUM CHLORIDE 216 203 11 30
DONEPEZIL HCL 212 212 12 17
ATENOLOL 206 193 13 13
TAMSULOSIN HCL 194 194 14 23
CRESTOR 182 165 15 18
ALENDRONATE SODIUM 175 165 16 29
MIRTAZAPINE 150 146 17 26
DIOVAN 149 149 18 16
PRAVASTATIN SODIUM 147 116 19 15
PANTOPRAZOLE SODIUM 145 138 20 32
METOPROLOL SUCCINATE 144 144 21 12
GABAPENTIN 144 139 21 20
NAMENDA 141 141 23 34
ESCITALOPRAM OXALATE 137 125 24 27
CITALOPRAM HBR 130 130 25 24
TRAZODONE HCL 127 127 26 21
ZOLPIDEM TARTRATE 125 103 27 14
LANTUS 113 113 28 43
CYMBALTA 112 89 29 41
OXYCODONE-ACETAMINOPHEN 111 98 S2 30 57
BENICAR 104 87 31 78
CARVEDILOL 102 102 32 36
IPRATROPIUM-ALBUTEROL 101 99 33 73
ADVAIR DISKUS 101 95 33 37
SERTRALINE HCL 99 99 35 19
PREDNISONE 98 96 36 33
JANUVIA 97 86 37 49
HYDROCODONE-ACETAMINOPHEN 92 91 S3 38 25
METFORMIN HCL ER 90 90 39 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 90 39 38
HYDROCHLOROTHIAZIDE 89 89 41 11
TRIAMTERENE-HCTZ 88 87 42 58
NEXIUM 87 67 43 28
PAROXETINE HCL 86 86 44 62
LOVASTATIN 77 77 45 44
CLOPIDOGREL 77 77 45 46
BENICAR HCT 74 69 47 120
SPIRIVA 74 74 47 48
GLIMEPIRIDE 68 61 49 50
BENAZEPRIL HCL 64 60 50 112
LOSARTAN POTASSIUM 64 64 50 22
GLIPIZIDE 64 64 50 69
AMLODIPINE BESYLATE-BENAZEPRIL 63 63 53 77
VENLAFAXINE HCL ER 63 57 53 105
FLUTICASONE PROPIONATE 60 52 55 55
HUMALOG 60 60 55 116
LIDODERM 60 60 55 66
TRICOR 59 48 58 101
FLUOXETINE HCL 59 59 58 85
TRAMADOL HCL 58 51 60 35
ZETIA 58 58 60 51
FINASTERIDE 58 58 60 76
ALLOPURINOL 58 56 60 31
AMITRIPTYLINE HCL 57 47 R 64 150
DIOVAN HCT 53 53 65 60
OXYCONTIN 52 37 S2 66 98
MELOXICAM 52 51 66 67
OXYCODONE HCL-ACETAMINOPHEN 52 31 S2 66 138
LIPITOR 51 49 69 47
HUMALOG MIX 75-25 50 50 70 388
PROPRANOLOL HCL 50 39 70 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.